XM2-26398-75608
1 vaccination
4 coded responses
9 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 381 / TN
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- THS-71869-30406
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-24
Dose 1 — ModernaCo-administered: Hib:Pneumonia
-
2022-06-30
Registered in v-safe
-
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain, Swelling/hardness · Fever · Irritability/crying · Be unable to work or attend schoolUnder 3 check-in
-
2022-07-03
Survey response — day 7, dose 1, under 3MedDRA: Faeces discoloured — Feeling: Good · Site: Swelling/hardnessFree text: Black stoolMedDRA releases: 2024-11 · check-in free text available
- 2022-07-08
- 2022-07-15
- 2022-07-22
-
2022-07-30
Survey response — day 35, dose 1, under 3MedDRA: Conjunctivitis, Ear infection — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Mild ear infection, bilateral conjunctivitisMedDRA releases: 2024-11 · check-in free text available
-
2022-07-30
Report sent to call center — day 35, dose 1, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-01
-
2022-08-02
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-05
-
2022-09-25
Survey response — 3 months, dose 1, under 3MedDRA: Otitis media, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: She had RSV and bilateral otitis media.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-25
Report sent to call center — 3 months, dose 1, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-26
-
2022-12-23
Survey response — 6 months, dose 1, under 3MedDRA: Cough, Diarrhoea, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Rhinorrhea, cough, congestion, diarrheaMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Moderna | Hib:Pneumonia |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 12 (Under 3) — day 7, dose 1, under 3
Systemic reaction (other): Black stool
Release 12 (Under 3) — day 35, dose 1, under 3
Symptoms: Mild ear infection, bilateral conjunctivitis
Release 12 (Under 3) — 3 months, dose 1, under 3
Symptoms: She had RSV and bilateral otitis media.
Release 12 (Under 3) — 6 months, dose 1, under 3
Symptoms: Rhinorrhea, cough, congestion, diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Otitis media | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Faeces discoloured | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release